SUMMARY One hundred and thirty two women with normal breast screening results were interviewed six months after their attendance at the Edinburgh Breast Screening Clinic. Eight percent of women said screening had made them more anxious about developing breast cancer. Thirty eight percent said they were more aware of the disease since screening but they regarded this as advantageous. Seventy percent of the women were still practising breast self-examination. There was no difference in the psychiatric morbidity of the screened sample when compared with a matched random sample community control group. Neither was there any difference in the General Health Questionnaire case rates before and after screening. Screening does not appear to increase the prevalence of psychiatric morbidity. Twenty nine percent of the interview sample were examining their breasts more than once a month-21% once a week or more. However, these frequent self-examiners did not have a greater prevalence of psychiatric morbidity than their matched controls.
There is increasing evidence that screening for breast cancer may lead to a worthwhile reduction in mortality from the disease,' 2 and a major trial to determine the effect of screening is under way in this country.3 However, screening may also have disadvantages, which should not be underestimated.4
For example, it is expensive when carried out on a population basis; some women undergo unnecessary treatment; and repeated mammography involves a radiation hazard, however small. A further disadvantage could be that screening causes an increase in anxiety about breast cancer among women who regularly attend and an increase in psychiatric morbidity. To our knowledge, this possibility has not been investigated. The study reported here was undertaken to examine the psychiatric morbidity of women who were screened within a randomir-d trial of screening for breast cancer in Edinburg..."
Methods
In Edinburgh, a breast screening trial is currently underway which involves all women in the city aged between 45 and 65 years; half of the women are randomly allocated (by general practice, not by individual) for invitation for screening, the other half acting as controls. General practitioners are allowed to exclude from invitation those with severe physical or psychiatric morbidity. Women allocated for screening are sent a letter offering an appointment at the Screening Clinic. Overall, 67% of women have accepted the invitation and have undergone clinical and mammographic examination. Those who attend are also taught breast self-examination.
The current study of psychiatric morbidity comprises three groups of women: a 1 in 8 "interview sample" randomly selected from the women who were attending the breast screening clinic for the first time over a two month period (16 March 1981 to 14 May 1981); a "postal sample", comprising all the women attending for screening for the first time in the week 25 May to 1 June 1981; a "control sample" selected from a random sample of women in Edinburgh to match the "interview sample".
A total of 151 women were included in the "interview sample" and were asked to fill in a 30-item general health questionnaire (GHQ) while waiting to be screened. The GHQ is a self rated screening questionnaire, which is used to screen for psychiatric morbidity in a population. status, and age (under 55 or 55 and over) with a woman from the general population sample. One hundred and seventeen of the 132 women were successfully matched; no match was found for 15 of the sample. Fortunately, no woman turned out to be her own control. The randomly selected control sample had also been interviewed using the PAS. Although other interviewers were involved, they had all been trained in the same way (as detailed above), and the same tutor (CD) was involved in training both groups of interviewers. Both sets of interviewers were assessed by the same passing out procedure.
Results
Six women from the interview sample were subsequently excluded because they were recalled to the clinic for further investigations. Of the 145 women eligible for interview, four refused at the clinic to be interviewed six months later (they were not approached subsequently) and five refused an interview when approached. An We compared the GHQ "case rate" before and six months after screening. Twenty eight of the interview sample were GHQ cases before screening compared with 28 after screening. Eighteen of the postal sample were GHQ cases before screening compared with 19 after screening. These differences were not significant. The mean symptom score of the interview and postal sample together before screening was 1 766 compared with 2-048 after screening. The difference in scores before and after screening was not significant (Wilcoxon matched-pairs signed-rank test). Twenty women were regarded as "cases" before screening and were "non-cases" six months later. Twenty one women who were "non-cases" before screening were "cases" six months later. Twenty six women were "cases" on both occasions.
The rest were "non-cases" on both occasions.
REPORTED EXPERIENCE OF SCREENING
Altogether 30% of women said they were made anxious by receiving the first letter of invitation, and 20% said they found the actual screening procedure to be anxiety provoking. Twice as many found the x-ray procedure upset them compared with the clinical examination. The screening procedure was found to be reassuring by 86% of women, and only 12 (9%) complained of not feeling reassured by the time they left the clinic. Four of these 12 (33%) women were cases at 12 months compared with 1 of the 12 matched controls. This difference was not significant. Six of these women had the PSE symptom of anxiety recorded compared with two of the control group, and this difference was significant (p<005). The pre-screening GHQ scores of these women were high (a mean score of 4-75) and this was significantly higher than the rest of the interview sample (mean 1-95; p<0-05; Mann Whitney U test). Their mean score six months after screening was lower (4.17) than before screening but still higher than that of the rest of the interview sample.
Before screening, 40% of women said they sometimes worried about the possibility of breast cancer. Six months after screening 39% of women said they sometimes worried. Only 10 women (7-6%) thought screening had made them more anxious about developing breast cancer (4 of these 10 were RDC cases six months after screening compared with none in the matched control group; this difference was significant FE p<005). Six of these women had the PSE symptom of anxiety compared with none of the controls (FE p<0-01). The prescreening GHQ scores (mean 2 3) of these women was not any higher than for the rest of the interview sample; nor was their mean GHQ score six months after screening Christine Dean, M Maureen Roberts, Kate French, and Susan Robinson (mean 3.0) higher than for the rest of the interview sample. The increase in mean GHQ score between the two times was not significant. This group of women differed from the rest of the interview sample in being more likely to be of lower social class (60% were IIIM, IV or V compared with 37% of the rest, p<O0 1). They also had a tendency to be older, more were divorced, separated or widowed, and were more likely to be employed (90%) than the rest of the interview sample.
More awareness of the disease as a result of screening was reported by 38% of women, but 93% of these thought that the increased awareness was a good thing.
BREAST SELF-EXAMINATION
Of the 132 women interviewed, 88 (67%) said they were still practising self-examination six months later. Only 31 (23.5%) were carrying it out at monthly intervals, 38 (29%) performing it more often, 27 (20.5%) of them once or more weekly.
However, only two women said breast self-examination made them anxious (and neither of these was an RDC case six months after screening), the majority (90%) claiming that they were reassured by the procedure. Women who examined their breast more frequently than once a month did not have a higher case rate than the matched control group; there were seven cases (18%) in both groups. There was no difference either in the number of women who had the PSE symptom of anxiety: nine in the screened sample compared with eight in the control group. They did have a non-significant tendency to be of lower social class than the rest of the interview sample, and more of them were divorced, widowed or separated.
Discussion
Most women did not find that going to the-breast screening clinic made them feel anxious about breast cancer. The numbers worrying about breast cancer before and after screening were about the same. However, this assessment was done retrospectively.. In a random sample of the population12 only 5% of women spontaneously mentioned breast cancer as an illness they personally worried about compared with 40% of women in this study before and six months after screening. However, the screened sample were asked directly if they worried about breast cancer, and this could account for the difference or it could be that screening had raised awareness about breast cancer.
Screening does not appear to increase psychiatric morbidity. There was no difference in the number of psychiatric cases established at interview six months after screening when compared with a matched sample of the population. It is possible that because of a type II error a small real difference between the screened population and the control group was not demonstrated. As already mentioned above, there was a non-significant tendency for those who came for screening to have a lower psychiatric morbidity than those who did not. Other studies have shown that non-attenders are of a lower social class than attenders,13 14 and those of a lower social class do have a higher psychiatric morbidity.9 However, we believe we have controlled for this bias by matching for social class, marital status, age, and employment status. Using the GHQ postal data gave us a larger sample size (n=269). However, even with a sample size of 269 a type II error may have prevented us from demonstrating a small but real difference in psychiatric morbidity before and after screening. Although the GHQ refers to symptoms in the few weeks before completing the questionnaire, the GHQ was, in this study, completed at a stressful time, that is, immediately before a first breast screening. This may have inflated the prescreening scores and may have concealed an increased symptom score after screening compared with the patients' true prescreening state.
Women in whom an abnormality was found and who had to return to the clinic were not included in the study. Thirty eight per 1000 women were asked to return (6/1000 women prove to have cancer: 12/1000 have biopsies for benign lesions: the rest have other investigations). It is not possible from our study to comment on the psychiatric morbidity after screening in this group; it requires a further study.
A small group of women (9%) complained of not being reassured by the time they left the clinic. They did not have a higher case rate than controls at six months but did have a higher number declaring the PSE symptom of anxiety. However, these women had higher GHQ scores before screening, and the likely explanation of their not feeling reassured is that they were particularly anxious women.
We found that large numbers of women were carrying out breast self-examination more frequently than recommended (more than once a month).
However, these women did not have an increased psychiatric case rate nor did they have increased rates of anxiety. It could be that they had failed to understand the instructions given to them at the screening clinic.
A small percentage of women (8%) felt that breast screening had made them feel anxious about developing breast cancer. This small group of women did in fact have a higher psychiatric morbidity than their matched control group. It could be that a small subgroup of women are vulnerable and that
